DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,950 | -1.9% | 21,423 | +23.2% | 0.00% | – |
| Q2 2023 | $195,660 | -13.0% | 17,392 | -10.9% | 0.00% | – |
| Q1 2023 | $224,836 | +5.4% | 19,517 | +6.1% | 0.00% | – |
| Q4 2022 | $213,256 | +18.5% | 18,400 | +29.7% | 0.00% | – |
| Q3 2022 | $180,000 | +83.7% | 14,191 | -0.4% | 0.00% | – |
| Q2 2022 | $98,000 | -37.6% | 14,249 | -12.6% | 0.00% | – |
| Q1 2022 | $157,000 | -27.6% | 16,309 | -10.6% | 0.00% | – |
| Q4 2021 | $217,000 | -22.8% | 18,247 | +5.6% | 0.00% | – |
| Q3 2021 | $281,000 | -25.1% | 17,273 | -3.1% | 0.00% | – |
| Q2 2021 | $375,000 | +151.7% | 17,830 | +85.7% | 0.00% | – |
| Q1 2021 | $149,000 | -40.4% | 9,602 | -19.2% | 0.00% | – |
| Q4 2020 | $250,000 | – | 11,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |